MK0524 Asthma POC Study (0524-008)(COMPLETED)

NCT00783601 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Comparator: MK0524 + placebo
DRUG: Comparator: MK0524 + montelukast
DRUG: Comparator: placebo + montelukast
DRUG: Comparator: Placebo

Sponsor

Merck Sharp & Dohme LLC